CapsoVision, Inc Proceeds from Other Equity
CapsoVision, Inc (CV) reported Proceeds from Other Equity of $121.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromOtherEquity · last filed 2026-08-13
- CapsoVision, Inc proceeds from other equity for the quarter ending 2026-06-30 was $82.00K, a 51.19% decline year-over-year.
- CapsoVision, Inc proceeds from other equity for the quarter ending 2026-03-31 was $39.00K, a 14.71% increase year-over-year.
- CapsoVision, Inc proceeds from other equity for the quarter ending 2025-12-31 was $15.00K, a 1400.00% increase year-over-year.
- CapsoVision, Inc proceeds from other equity for the quarter ending 2025-09-30 was $14.00K.
- CapsoVision, Inc proceeds from other equity for fiscal 2025 was $231.00K, a 212.16% increase from fiscal 2024.
- CapsoVision, Inc proceeds from other equity for fiscal 2024 was $74.00K.
| Period end | Proceeds from Other Equity 3 month | Proceeds from Other Equity 6 month | Proceeds from Other Equity 9 month | Proceeds from Other Equity 12 month |
|---|---|---|---|---|
| 2026-06-30 | $82.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $121.00K 10-Q · filed 2026-08-13 | $136.00K derived: sum of 3 quarters · filed 2026-08-13 | $150.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $39.00K 10-Q · filed 2026-05-14 | $54.00K derived: sum of 2 quarters · filed 2026-05-14 | $68.00K derived: sum of 3 quarters · filed 2026-05-14 | $236.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $29.00K derived: sum of 2 quarters · filed 2026-03-26 | $197.00K derived: sum of 3 quarters · filed 2026-08-13 | $231.00K 10-K · filed 2026-03-26 |
| 2025-09-30 | $14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $182.00K derived: sum of 2 quarters · filed 2026-08-13 | $216.00K 10-Q · filed 2025-11-13 | $217.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $168.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $202.00K 10-Q · filed 2026-08-13 | $203.00K derived: sum of 3 quarters · filed 2026-08-13 | |
| 2025-03-31 | $34.00K 10-Q · filed 2026-05-14 | $35.00K derived: sum of 2 quarters · filed 2026-05-14 | ||
| 2024-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $74.00K 10-K · filed 2026-03-26 | ||
| 2024-09-30 | $73.00K 10-Q · filed 2025-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B |